Harmony Biosciences Holdings, Inc. Common Stock Earnings Dividend

Harmony Biosciences Holdings, Inc. Common Stock’s revenue jumped 30.32% since last year same period to $261.28Mn in the Q2 2026. On a quarterly growth basis, Harmony Biosciences Holdings, Inc. Common Stock has generated 21.31% jump in its revenue since last 3-months.

Harmony Biosciences Holdings, Inc. Common Stock’s net profit jumped 89.64% since last year same period to $75.43Mn in the Q2 2026. On a quarterly growth basis, Harmony Biosciences Holdings, Inc. Common Stock has generated 132.18% jump in its net profits since last 3-months.

Harmony Biosciences Holdings, Inc. Common Stock’s net profit margin jumped 45.52% since last year same period to 28.87% in the Q2 2026. On a quarterly growth basis, Harmony Biosciences Holdings, Inc. Common Stock has generated 91.4% jump in its net profit margins since last 3-months.

Harmony Biosciences Holdings, Inc. Common Stock’s earning per share (EPS) estimates for the current quarter stand at 0.97 - a 4.3% jump from last quarter’s estimates.

Harmony Biosciences Holdings, Inc. Common Stock’s earning per share (EPS) estimates for the current year stand at 0.97.

Harmony Biosciences Holdings, Inc. Common Stock’s earning per share (EPS) jumped 39.13% since last year same period to 1.28 in the Q2 2026. This indicates that the Harmony Biosciences Holdings, Inc. Common Stock has generated 39.13% annual rate of jump in its earning per share (EPS) in the last 4 quarters.